SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-104988
Filing Date
2023-04-18
Accepted
2023-04-18 16:09:02
Documents
13
Period of Report
2023-04-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d498064d8k.htm   iXBRL 8-K 36811
2 EX-2.1 d498064dex21.htm EX-2.1 375920
  Complete submission text file 0001193125-23-104988.txt   612028

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lhdxq-20230412.xsd EX-101.SCH 2526
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lhdxq-20230412_lab.xml EX-101.LAB 17987
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lhdxq-20230412_pre.xml EX-101.PRE 11244
7 EXTRACTED XBRL INSTANCE DOCUMENT d498064d8k_htm.xml XML 3497
Mailing Address 1315 63RD STREET EMERYVILLE CA 94608
Business Address 1315 63RD STREET EMERYVILLE CA 94608 (814) 574-1546
Lucira Health, Inc. (Filer) CIK: 0001652724 (see all company filings)

IRS No.: 272491037 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39976 | Film No.: 23826924
SIC: 2835 In Vitro & In Vivo Diagnostic Substances